About this trial
The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Written informed consent
Adequate fresh or archival tumor biopsy or intent to obtain fresh tumor biopsy.
T-cell prolymphocytic leukemia
T-cell large granular lymphocytic leukemia
Disqualifiers
Patients with of mycosis fungoides, primary cutaneous anaplastic large cell lymphoma, and/or primary cutaneous acral CD8+ T-cell lymphoma not receiving systemic therapy.
Inability to collect prospective data, measure response, or perform adequate follow-up assessments in the clinical judgment of the treating physician. NOTE: Repository participation does not exclude participation in clinical trials, nor does existing clinical trial participation exclude enrollment in the study herein outlined.
Trial population
Participants at Memorial Sloan Kettering Cancer Center (MSKCC) will be recruited through the Lymphoma service in the Department of Medicine and the Department of Pediatrics. Participants will be recruited at the participating centers.
Trial design
Cohort
Prospective
Treatments tested in this trial
Optional Blood Sample and Nail Sample
Other interventionParticipants may provide optional research blood and nail samples for biobanking and future use
Treatment groups
Trial outcomes
Primary outcomes
Number of participants populating the T-cell Lymphoma Master Repository/TCLMR
To develop and populate a secure database comprised of patients with T-cell lymphomas with curated clinical characteristics and treatment outcomes matched to pathological biospecimens.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.